최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기생명과학회지 = Journal of life science, v.29 no.11, 2019년, pp.1258 - 1266
한도경 (부산대학교 한의학전문대학원 한의학과) , 박맑은 (부산대학교 한의학전문대학원 한의과학과) , 권옥선 (부산대학교 한의학전문대학원 한의학과) , 최병태 (부산대학교 한의학전문대학원 한의학과)
Yangkyuksanhwa-Tang (YKSH), consisting of nine different herbs, is commonly used in Soyangin-type individuals with stroke, based on the Sasang Constitution Theory in Korea. However, no evidence has yet confirmed a beneficial effect of YKSH in ischemic stroke treatment. In this study, we investigated...
* AI 자동 식별 결과로 적합하지 않은 문장이 있을 수 있으니, 이용에 유의하시기 바랍니다.
Anderson, M. A., Burda, J. E., Ren, Y., Ao, Y., O'Shea, T. M., Kawaguchi, R., Coppola, G., Khakh, B. S., Deming, T. J. and Sofroniew, M. V. 2016. Astrocyte scar formation aids central nervous system axon regeneration. Nature 532, 195-200.
Breckwoldt, M. O., Chen, J. W., Stangenberg, L., Aikawa, E., Rodriguez, E., Qiu, S., Moskowitz, M. A. and Weissleder, R. 2008. Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase. Proc. Natl. Acad. Sci. USA. 105, 18584-18589.
Burns, J. J., Zhao, L., Taylor, E. W. and Spelman, K. 2010. The influence of traditional herbal formulas on cytokine activity. Toxicology 278, 140-159.
Chen, Z. and Trapp, B. D. 2016. Microglia and neuroprotection. J. Neurochem. 136 Suppl 1, 10-17.
Choudhury, G. R. and Ding, S. 2016. Reactive astrocytes and therapeutic potential in focal ischemic stroke. Neurobiol. Dis. 85, 234-244.
de Lima, N. M., Ferreira, E. O., Fernandes, M. Y., Lima, F. A., Neves, K. R., do Carmo, M. R. and de Andrade, G. M. 2017. Neuroinflammatory response to experimental stroke is inhibited by boldine. Behav. Pharmacol. 28, 223-237.
Fernandes, M. Y. D., Carmo, M. R. S. D., Fonteles, A. A., Neves, J. C. S., Silva, A. T. A. D., Pereira, J. F., Ferreira, E. O., Lima, N. M. R., Neves, K. R. T. and Andrade, G. M. 2019. (-)-alpha-bisabolol prevents neuronal damage and memory deficits through reduction of proinflammatory markers induced by permanent focal cerebral ischemia in mice. Eur. J. Pharmacol. 842, 270-280.
Gu, Y., Chen, J. and Shen, J. 2014. Herbal medicines for ischemic stroke: combating inflammation as therapeutic targets. J. Neuroimmune Pharmacol. 9, 313-339.
Huang, J., Li, Y., Tang, Y., Tang, G., Yang, G. Y. and Wang, Y. 2013. CXCR4 antagonist AMD3100 protects blood-brain barrier integrity and reduces inflammatory response after focal ischemia in mice. Stroke 44, 190-197.
Iadecola, C. and Anrather, J. 2011. The immunology of stroke: from mechanisms to translation. Nat. Med. 17, 796-808.
Jeffers, M. S. and Corbett, D. 2018. Synergistic effects of enriched environment and task-specific reach training on poststroke recovery of motor function. Stroke 49, 1496-1503.
Lee, J. M. 2003. Dongeui Soosebowon. Yeogang, Seoul, Republic of Korea.
Jeong, H. J., Hong, S. H., Park, H. J., Kweon, D. Y., Lee, S. W., Lee, J. D., Kim, K. S., Cho, K. H., Kim, H. S., Kim, K. Y. and Kim, H. M. 2002. Yangkyuk-Sanhwa-Tang induces changes in serum cytokines and improves outcome in focal stroke patients. Vascul. Pharmacol. 39, 63-68.
Jeong, H. J., Lee, H. J., Hong, S. H., Kim, H. M. and Um, J. Y. 2007. Inhibitory effect of Yangkyuk-Sanhwa-Tang on inflammatory cytokine production in peripheral blood mononuclear cells from the cerebral infarction patients. Int. J. Neurosci. 117, 525-537.
Langhorne, P., Bernhardt, J. and Kwakkel, G. 2011. Stroke rehabilitation. Lancet 377, 1693-1702.
Lapchak, P. A., Chapman, D. F. and Zivin, J. A. 2001. Pharmacological effects of the spin trap agents N-t-butyl-phenylnitrone (PBN) and 2,2,6, 6-tetramethylpiperidine-N-oxyl (TEMPO) in a rabbit thromboembolic stroke model: combination studies with the thrombolytic tissue plasminogen activator. Stroke 32, 147-153.
Li, S. 2017. Spasticity, Motor Recovery, and Neural Plasticity after Stroke. Front. Neurol. 8, 120.
Liguz-Lecznar, M., Zakrzewska, R. and Kossut, M. 2015. Inhibition of Tnf-alpha R1 signaling can rescue functional cortical plasticity impaired in early post-stroke period. Neurobiol. Aging 36, 2877-2884.
Lindekleiv, H., Berge, E., Bruins Slot, K. M. and Wardlaw, J. M. 2018. Percutaneous vascular interventions versus intravenous thrombolytic treatment for acute ischaemic stroke. Cochrane Database Syst. Rev. 10, CD009292.
Liu, L., Vollmer, M. K., Fernandez, V. M., Dweik, Y., Kim, H. and Dore, S. 2018a. Korean Red Ginseng pretreatment protects against long-term sensorimotor deficits after ischemic stroke likely through Nrf2. Front. Cell. Neurosci. 12, 74.
Liu, S., Feng, X., Jin, R. and Li, G. 2018b. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke. Expert Opin. Drug Deliv. 15, 173-184.
Minagar, A., Long, A., Ma, T., Jackson, T. H., Kelley, R. E., Ostanin, D. V., Sasaki, M., Warren, A. C., Jawahar, A., Cappell, B. and Alexander, J. S. 2003. Interferon (IFN)-beta 1a and IFN-beta 1b block IFN-gamma-induced disintegration of endothelial junction integrity and barrier. Endothelium 10, 299-307.
Minnerup, J., Sutherland, B. A., Buchan, A. M. and Kleinschnitz, C. 2012. Neuroprotection for stroke: current status and future perspectives. Int. J. Mol. Sci. 13, 11753-11772.
Parent, J. M., Vexler, Z. S., Gong, C., Derugin, N. and Ferriero, D. M. 2002. Rat forebrain neurogenesis and striatal neuron replacement after focal stroke. Ann. Neurol. 52, 802-813.
Peng, T., Jiang, Y., Farhan, M., Lazarovici, P., Chen, L. and Zheng, W. 2019. Anti-inflammatory effects of traditional Chinese medicines on preclinical in vivo models of brain ischemia-reperfusion-injury: prospects for neuroprotective drug discovery and therapy. Front. Pharmacol. 10, 204.
Sandvig, I., Augestad, I. L., Haberg, A. K. and Sandvig, A. 2018. Neuroplasticity in stroke recovery. The role of microglia in engaging and modifying synapses and networks. Eur. J. Neurosci. 47, 1414-1428.
Shin, M. G., Song, I. B and Son, S. K. 2001. Effects of Yanggyuksanhwa-Tang on cerebral blood flow and ischemic brain damage in rats. Journal of Sasang Constitutional Medicine 13, 165-176.
Widmann, C., Gandin, C., Petit-Paitel, A., Lazdunski, M. and Heurteaux, C. 2018. The traditional Chinese medicine MLC 901 inhibits inflammation processes after focal cerebral ischemia. Sci. Rep. 8, 18062.
Zhang, X., Zhao, H. H., Li, D. and Li, H. P. 2019. Neuroprotective effects of matrix metalloproteinases in cerebral ischemic rats by promoting activation and migration of astrocytes and microglia. Brain Res. Bull. 146, 136-142.
Zhang, Z. G. and Chopp, M. 2009. Neurorestorative therapies for stroke: underlying mechanisms and translation to the clinic. Lancet Neurol. 8, 491-500.
Zimmermann, G. R., Lehar, J. and Keith, C. T. 2007. Multi-target therapeutics: when the whole is greater than the sum of the parts. Drug Discov. Today 12, 34-42.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.